163 related articles for article (PubMed ID: 7495984)
1. Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1.
Sympson CJ; Bissell MJ; Werb Z
Semin Cancer Biol; 1995 Jun; 6(3):159-63. PubMed ID: 7495984
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis.
Werb Z; Ashkenas J; MacAuley A; Wiesen JF
Braz J Med Biol Res; 1996 Sep; 29(9):1087-97. PubMed ID: 9181050
[TBL] [Abstract][Full Text] [Related]
3. Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse.
Li F; Strange R; Friis RR; Djonov V; Altermatt HJ; Saurer S; Niemann H; Andres AC
Int J Cancer; 1994 Nov; 59(4):560-8. PubMed ID: 7960227
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development.
Witty JP; Wright JH; Matrisian LM
Mol Biol Cell; 1995 Oct; 6(10):1287-303. PubMed ID: 8573787
[TBL] [Abstract][Full Text] [Related]
5. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
Witty JP; Lempka T; Coffey RJ; Matrisian LM
Cancer Res; 1995 Apr; 55(7):1401-6. PubMed ID: 7882342
[TBL] [Abstract][Full Text] [Related]
6. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression.
Sympson CJ; Talhouk RS; Alexander CM; Chin JR; Clift SM; Bissell MJ; Werb Z
J Cell Biol; 1994 May; 125(3):681-93. PubMed ID: 8175886
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of stromelysin-1 gene expression is altered during progression of mouse mammary epithelial cells from functionally normal to malignant.
Lochter A; Werb Z; Bissell MJ
Matrix Biol; 1999 Oct; 18(5):455-67. PubMed ID: 10601733
[TBL] [Abstract][Full Text] [Related]
8. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development.
Thomasset N; Lochter A; Sympson CJ; Lund LR; Williams DR; Behrendtsen O; Werb Z; Bissell MJ
Am J Pathol; 1998 Aug; 153(2):457-67. PubMed ID: 9708806
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.
Ha HY; Moon HB; Nam MS; Lee JW; Ryoo ZY; Lee TH; Lee KK; So BJ; Sato H; Seiki M; Yu DY
Cancer Res; 2001 Feb; 61(3):984-90. PubMed ID: 11221894
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix remodeling and the regulation of epithelial-stromal interactions during differentiation and involution.
Werb Z; Sympson CJ; Alexander CM; Thomasset N; Lund LR; MacAuley A; Ashkenas J; Bissell MJ
Kidney Int Suppl; 1996 May; 54():S68-74. PubMed ID: 8731199
[TBL] [Abstract][Full Text] [Related]
11. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM
Cancer Res; 1998 Dec; 58(23):5500-6. PubMed ID: 9850086
[TBL] [Abstract][Full Text] [Related]
12. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.
Sternlicht MD; Bissell MJ; Werb Z
Oncogene; 2000 Feb; 19(8):1102-13. PubMed ID: 10713697
[TBL] [Abstract][Full Text] [Related]
13. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
14. Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Andarawewa KL; Boulay A; Masson R; Mathelin C; Stoll I; Tomasetto C; Chenard MP; Gintz M; Bellocq JP; Rio MC
Cancer Res; 2003 Sep; 63(18):5844-9. PubMed ID: 14522908
[TBL] [Abstract][Full Text] [Related]
15. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix.
Boudreau N; Sympson CJ; Werb Z; Bissell MJ
Science; 1995 Feb; 267(5199):891-3. PubMed ID: 7531366
[TBL] [Abstract][Full Text] [Related]
16. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene.
Alexander CM; Howard EW; Bissell MJ; Werb Z
J Cell Biol; 1996 Dec; 135(6 Pt 1):1669-77. PubMed ID: 8978831
[TBL] [Abstract][Full Text] [Related]
17. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties.
Lochter A; Srebrow A; Sympson CJ; Terracio N; Werb Z; Bissell MJ
J Biol Chem; 1997 Feb; 272(8):5007-15. PubMed ID: 9030563
[TBL] [Abstract][Full Text] [Related]
18. The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.
Sampayo R; Recouvreux S; Simian M
Vitam Horm; 2013; 93():185-201. PubMed ID: 23810007
[TBL] [Abstract][Full Text] [Related]
19. The role of stromelysin-1 in stromal-epithelial interactions and cancer.
Wiesen JF; Werb Z
Enzyme Protein; 1996; 49(1-3):174-81. PubMed ID: 8797005
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
